Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q2 2017 · 10-Q
Revenue$16.94M$16.94M−6.5% vs Q2 2016 Net Income-$1.11M-$1.11MN/M vs Q2 2016 EPS Diluted-$0.05-$0.05N/M vs Q2 2016 Gross Profit$10,341,000−7.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,673,000+74.5% Free Cash Flowderived$1,795,000N/M Margins · derivedGross margin61.0%−0.4 pt vs Q2 2016
Operating margin-6.4%−8.9 pt vs Q2 2016
Net margin-6.5%−7.4 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 9, 2017 · 40 d after period end